Results 151 to 160 of about 9,329 (213)

An analysis of national guidelines for the prevention, diagnosis and treatment of cryptococcal meningitis in sub-Saharan African countries: gaps and opportunities. [PDF]

open access: yesBMJ Glob Health
Walker RS   +11 more
europepmc   +1 more source

Multifocal Intracranial Cryptococcoma with Treatment Resistance, Recurrence, and Mortality: A Case Report and Literature Review. [PDF]

open access: yesNMC Case Rep J
Higashino M   +8 more
europepmc   +1 more source

In Vitro Antifungal Combination of Flucytosine with Amphotericin B, Voriconazole, or Micafungin against Candida auris Shows No Antagonism

open access: yesAntimicrobial Agents and Chemotherapy, 2019
International audienceCandida auris is an emerging, multidrug-resistant pathogen responsible for invasive hospital-acquired infections. Flucytosine is an effective anti- Candida species drug, but which cannot be used as a monotherapy because of the risk ...
Françoise Botterel   +2 more
exaly   +2 more sources

Pharmacodynamics of Liposomal Amphotericin B and Flucytosine for Cryptococcal Meningoencephalitis: Safe and Effective Regimens for Immunocompromised Patients

open access: yesJournal of Infectious Diseases, 2013
Background. Cryptococcal meningoencephalitis is a lethal infection with relatively few therapeutic options. The optimal dosage of liposomal amphotericin B (LAmB) alone or in combination with flucytosine is not known.Methods.
Joanne Livermore   +2 more
exaly   +2 more sources

Flucytosine

Drug and Therapeutics Bulletin, 1975
Flucytosine (5-fluorocytosine; 5FC; Alcobon - Roche) is a synthetic antifungal drug which is active when given orally. It is an analogue of the pyrimidine base cytosine, and probably acts by being deaminated to 5-fluorouracil which behaves as a pyrimidine antimetabolite during nucleic acid synthesis.1
openaire   +3 more sources

Home - About - Disclaimer - Privacy